Amprius Technologies (NYSE:AMPX) Trading Down 8.5% – Time to Sell?

Amprius Technologies, Inc. (NYSE:AMPX)’s share price traded down 8.5% during mid-day trading on Friday . The stock traded as low as $12.20 and last traded at $12.42. 11,475,794 shares were traded during trading, an increase of 36% from the average session volume of 8,412,326 shares. The stock had previously closed at $13.58.

Amprius Technologies News Roundup

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Needham initiated coverage with a Buy and a $20 price target (roughly +61% upside from current levels), a bullish analyst catalyst that likely drew buyer interest and helped fuel recent gains. Needham initiates coverage of Amprius
• Positive Sentiment: MarketBeat highlighted Amprius’ expanding production capacity and new South Korean manufacturing partners, noting the company is ahead of plan and positioning for an improved path to profitability ahead of FY2025 Q4 results (late March) — a concrete operational improvement that supports longer‑term upside. 5 Stocks to Buy in February: Last Year’s Winners Aren’t Done Yet (AMPX)
• Positive Sentiment: Unusual options activity: a large purchase of call options (22,391 contracts) suggests elevated bullish/speculative interest and short‑term upside betting by traders — this can amplify intraday moves and volatility.
• Neutral Sentiment: Several outlets ran takeaways asking whether recent multi‑month gains make AMPX “too late” to buy and examining valuation after a big run; these pieces increase retail attention but don’t settle fundamentals one way or the other. Is It Too Late To Consider Buying Amprius Technologies (AMPX)
• Negative Sentiment: Zacks noted a recent sharp intraday gain but flagged that the trend in earnings‑estimate revisions does not support sustained upside — a warning that analysts’ expectations may not be accelerating enough to justify the rally. Amprius (AMPX) Moves 13.4% Higher: Will This Strength Last?
• Negative Sentiment: Fundamental risk: Amprius still shows negative net margin and negative ROE and trades with a high beta — meaning the stock is sensitive to sentiment swings and could face profit‑taking or re‑rating if upcoming earnings fail to show clear progress toward profitability.

Wall Street Analyst Weigh In

Several brokerages recently commented on AMPX. Northland Securities set a $20.00 target price on Amprius Technologies in a research report on Tuesday, October 7th. Needham & Company LLC assumed coverage on Amprius Technologies in a research note on Thursday. They issued a “buy” rating and a $20.00 price target on the stock. Cantor Fitzgerald increased their price target on Amprius Technologies from $12.00 to $16.00 and gave the stock an “overweight” rating in a report on Friday, November 7th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Amprius Technologies in a research note on Wednesday, January 21st. Finally, Oppenheimer reiterated an “outperform” rating and set a $17.00 target price on shares of Amprius Technologies in a research report on Tuesday, December 23rd. Seven investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, Amprius Technologies currently has an average rating of “Moderate Buy” and an average target price of $16.57.

Amprius Technologies Stock Performance

The firm’s fifty day moving average is $10.23 and its 200-day moving average is $9.98. The company has a market capitalization of $1.62 billion, a P/E ratio of -47.77 and a beta of 3.04.

Amprius Technologies (NYSE:AMPX) last issued its quarterly earnings data on Thursday, November 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.03. The company had revenue of $21.43 million during the quarter, compared to the consensus estimate of $16.45 million. Amprius Technologies had a negative return on equity of 38.85% and a negative net margin of 53.16%. As a group, analysts expect that Amprius Technologies, Inc. will post -0.45 EPS for the current fiscal year.

Insider Buying and Selling at Amprius Technologies

In other news, Director Kang Sun sold 43,185 shares of the stock in a transaction dated Tuesday, January 20th. The shares were sold at an average price of $11.03, for a total value of $476,330.55. Following the sale, the director directly owned 1,403,651 shares of the company’s stock, valued at approximately $15,482,270.53. This represents a 2.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CTO Constantin Ionel Stefan sold 492,827 shares of the stock in a transaction on Thursday, January 22nd. The stock was sold at an average price of $12.04, for a total value of $5,933,637.08. Following the completion of the sale, the chief technology officer owned 748,696 shares in the company, valued at $9,014,299.84. This trade represents a 39.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 3,359,641 shares of company stock valued at $36,572,335. Insiders own 12.90% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Voloridge Investment Management LLC bought a new stake in shares of Amprius Technologies in the third quarter worth about $19,737,000. BNP Paribas Financial Markets lifted its holdings in Amprius Technologies by 1,117.9% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,943,905 shares of the company’s stock worth $20,450,000 after buying an additional 1,784,291 shares during the period. Vanguard Group Inc. grew its position in shares of Amprius Technologies by 37.0% in the 3rd quarter. Vanguard Group Inc. now owns 6,512,620 shares of the company’s stock worth $68,513,000 after buying an additional 1,757,395 shares during the last quarter. Invesco Ltd. grew its position in shares of Amprius Technologies by 113.3% in the 3rd quarter. Invesco Ltd. now owns 2,379,384 shares of the company’s stock worth $25,031,000 after buying an additional 1,263,846 shares during the last quarter. Finally, Stephens Investment Management Group LLC purchased a new position in shares of Amprius Technologies during the third quarter valued at approximately $11,392,000. 5.04% of the stock is currently owned by institutional investors.

Amprius Technologies Company Profile

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.